AU4335099A - Surface targeted expression of a modified hepatitis c virus envelope protein - Google Patents

Surface targeted expression of a modified hepatitis c virus envelope protein

Info

Publication number
AU4335099A
AU4335099A AU43350/99A AU4335099A AU4335099A AU 4335099 A AU4335099 A AU 4335099A AU 43350/99 A AU43350/99 A AU 43350/99A AU 4335099 A AU4335099 A AU 4335099A AU 4335099 A AU4335099 A AU 4335099A
Authority
AU
Australia
Prior art keywords
envelope protein
virus envelope
targeted expression
modified hepatitis
surface targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43350/99A
Inventor
Jens Bukh
Suzanne U Emerson
Xavier Forns
Robert H. Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU4335099A publication Critical patent/AU4335099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU43350/99A 1998-06-18 1999-06-04 Surface targeted expression of a modified hepatitis c virus envelope protein Abandoned AU4335099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8977998P 1998-06-18 1998-06-18
US60089779 1998-06-18
PCT/US1999/012665 WO1999066033A1 (en) 1998-06-18 1999-06-04 Surface targeted expression of a modified hepatitis c virus envelope protein

Publications (1)

Publication Number Publication Date
AU4335099A true AU4335099A (en) 2000-01-05

Family

ID=22219543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43350/99A Abandoned AU4335099A (en) 1998-06-18 1999-06-04 Surface targeted expression of a modified hepatitis c virus envelope protein

Country Status (2)

Country Link
AU (1) AU4335099A (en)
WO (1) WO1999066033A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395666B1 (en) 1999-09-29 2002-05-28 Phillips Petroleum Company Organometal catalyst compositions
AU2001279193A1 (en) * 2000-08-02 2002-02-13 Xencor Methods and compositions for the construction and use of viral envelops as display particles
KR100894150B1 (en) * 2004-06-25 2009-04-22 가부시끼가이샤 센단세메이가가꾸겐큐죠 Hcv rna having novel sequence
CN104324373B (en) * 2010-11-26 2018-10-09 麦克法兰博尼特医学健康研究公司 Composition and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610009A (en) * 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
PT773957E (en) * 1994-07-29 2005-11-30 Chiron Corp HEPATITIS C INNOVATIVE HEPATITIS E1 AND E2 POLYPEPTIDES, AND METHODS OF OBTAINING THEMSELVES
CA2223277A1 (en) * 1995-06-07 1996-12-19 Abbott Laboratories Method for detection of antibody to hepatitis c virus second envelope glycoprotein
JP2001503260A (en) * 1996-10-23 2001-03-13 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア Improved vaccine
ES2328536T3 (en) * 1997-05-06 2009-11-13 Novartis Vaccines And Diagnostics, Inc. INTRACELLULAR PRODUCTION OF POLYPEPTIDE E2 TRUNCATED FROM HEPATITIS C.

Also Published As

Publication number Publication date
WO1999066033A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
AU2933797A (en) Synthetic inhibitors of hepatitis c virus ns3 protease
PL324906A1 (en) Vaccines against viral hepatitis of c type
AU5285899A (en) Anti hepatitis c virus antibody and uses thereof
AU2550995A (en) Hepatitis c virus asialoglycoproteins
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
PL321966A1 (en) Vaccine against viral hepatitis of b type
AU8906898A (en) Crystals of hepatitis c virus helicase or fragments thereof comprising a helicase binding pocket
AU7063598A (en) Hepatitis c ns3 protease inhibitors
AU8740398A (en) Amplification of nucleic acids
AU3714499A (en) Hepatitis c virus mimotopes
ZA9811316B (en) Novel hepatitis C virus NS5B protein
AU7602800A (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
AU1629197A (en) Expression of a foamy virus envelope protein
AU5320296A (en) Modified viral envelope polypeptide
EP1141255A4 (en) Modified forms of hepatitis c virus ns3 protease
EP1100545A4 (en) Regulated expression of recombinant proteins using rna viruses
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
AU4335099A (en) Surface targeted expression of a modified hepatitis c virus envelope protein
AU9494998A (en) (in vivo), animal model for expression of hepatitis c virus
IL138804A0 (en) Hepatitis c virus ns5b nucleic acids and proteins
AU2241699A (en) Expression of proteolytically-sensitive peptides
AU6221996A (en) Oligonucleotides specific for hepatitis c virus
AU4415099A (en) Inhibition of viral infection and spread with viral and rhoa-derived peptides
AU5216198A (en) Transgenic virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase